Open AccessPemetrexed with or without Matuzumab as Second-Line Treatment for Patients with Stage IIIB/IV Non-small Cell Lung Cancer
Author(s) -
Joan H. Schiller,
Joachim von Pawel,
Philipp Schütt,
Rafat Ansari,
Michael Thomas,
Mansoor N. Saleh,
Robert McCroskey,
Wolfgang Pfeifer,
Thomas Marsland,
Goetz Kloecker,
Martin Sebastian,
Robert Pirker,
Raffael Kurek,
Claire Beadman,
Mark A. Socinski
Publication year - 2010
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/zpq6-ck16
Subject(s) - pemetrexed , medicine , stage (stratigraphy) , second line treatment , oncology , lung cancer , second line , first line , chemotherapy , biology , cisplatin , paleontology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom